Orbital Lymphoma: Prognostic Evaluation of a Rare Variant of Non-Hodgkin's Lymphoma with 18F-FDG PET-CT

Authors

  • Afroja Sultana Medical officer & MD resident, National Institute of Nuclear Medicine & Allied Sciences (NINMAS)
  • Md Abu Bakker Siddique Professor & CMO, NINMAS
  • Pupree Mutsuddy Associate Professor, National Institute of Nuclear Medicine & Allied Sciences (NINMAS)
  • Tapati Mandal Assistant Professor & SMO, National Institute of Nuclear Medicine & Allied Sciences (NINMAS)
  • Papia Akhter Assistant Professor & SMO, National Institute of Nuclear Medicine & Allied Sciences (NINMAS)
  • M M Ruhul Amin Assistant Surgeon & Endocrinologist, DGHS
  • A K M Fazlul Bari Professor & Director, National Institute of Nuclear Medicine & Allied Sciences (NINMAS)

DOI:

https://doi.org/10.3329/bjnm.v29i1.89302

Keywords:

¹⁸F-FDG PET/CT, orbital lymphoma, non-Hodgkin lymphoma chemiluminescence immune assay, seasonal variation, gender difference

Abstract

Lymphomas located in the orbit and surrounding structures are uncommon cancers, accounting for just 1% of all non-Hodgkin lymphoma cases. Most non-Hodgkin lymphomas of the orbit are classified as extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue type. Due to the non-specific nature of the clinical signs and symptoms, there may be some delays in reaching a diagnosis. The purpose of our study is to evaluate the prognostic value of PET-CT after therapy, as well as the clinical course of lymphomas that involve the orbit.

Bangladesh J. Nuclear Med. 29(1): 116-119, 2026

Downloads

Download data is not yet available.
Abstract
0
PDF
0

Downloads

Published

2026-05-19

How to Cite

Sultana, A., Siddique, M. A. B., Mutsuddy, P., Mandal, T., Akhter, P., Amin, M. M. R., & Bari, A. K. M. F. (2026). Orbital Lymphoma: Prognostic Evaluation of a Rare Variant of Non-Hodgkin’s Lymphoma with 18F-FDG PET-CT. Bangladesh Journal of Nuclear Medicine, 29(1), 116–119. https://doi.org/10.3329/bjnm.v29i1.89302

Issue

Vol. 29 No. 1 (2026)

Section

Case Reports

License

All rights reserved to Editor-in-Chief, Bangladesh Journal of Nuclear Medicine, Society of Nuclear Medicine, Bangladesh